Home Newsfeeds Keybanc Initiates Coverage On Stryker with Sector Weight Rating

Keybanc Initiates Coverage On Stryker with Sector Weight Rating

Keybanc analyst Matthew Mishan initiates coverage on Stryker (NYSE:SYK) with a Sector Weight rating.

byBenzinga Newsdesk

January 25, 2023

1 minute read

Keybanc analyst Matthew Mishan initiates coverage on Stryker (NYSE:SYK) with a Sector Weight rating.

Recap: Freeport-McMoRan Q2 Earnings

By Benzinga Insights

July 21, 8:26 AM

Freeport-McMoRan (NYSE:FCX) reported its Q2 earnings results on Thursday, July 21, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

FCX

Stifel Initiates Coverage On Relay Therapeutics with Buy Rating, Announces Price Target of $40

By Benzinga Newsdesk

September 2, 4:55 AM

Stifel analyst Bradley Canino initiates coverage on Relay Therapeutics (NASDAQ:RLAY) with a Buy rating and announces Price Target of $40.

RLAY

Pfizer’s Cost-Cutting Measures: 500 Job Cuts in Kent Facility, Higher Than Anticipated

By Vandana Singh

November 14, 1:15 PM

Pfizer Inc (NYSE: PFE) is reportedly discontinuing its pharmaceutical sciences small molecule (PSSM) operations at Sandwich in Kent to streamline operations and enhance efficiency. The decision will result in significant job cuts, with plans to eliminate 500 out of 940 positions.

PFE

Analysts Are Bullish On Seagen’s Catalyst-Rich Pipeline, Finding No Problem With No M&A

By Vandana Singh

February 16, 12:48 PM

Seagen Inc (NASDAQ:SGEN) reported a Q4 EPS loss of $(0.80), better than the consensus of $(1.05) and $(0.95) a year…

SGEN

Keybanc Initiates Coverage On Stryker with Sector Weight Rating

Related Posts

Recap: Freeport-McMoRan Q2 Earnings

Stifel Initiates Coverage On Relay Therapeutics with Buy Rating, Announces Price Target of $40

Pfizer’s Cost-Cutting Measures: 500 Job Cuts in Kent Facility, Higher Than Anticipated

Analysts Are Bullish On Seagen’s Catalyst-Rich Pipeline, Finding No Problem With No M&A